Pregnancy outcomes for simultaneous Pancreas-Kidney transplant recipients versus kidney transplant recipients.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
01 2021
Historique:
received: 25 03 2020
revised: 25 10 2020
accepted: 02 11 2020
pubmed: 13 11 2020
medline: 24 6 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Data about pregnancy outcomes for simultaneous pancreas-kidney transplant recipients (SPKR) are limited. We compared pregnancy outcomes in SPKR to Kidney Transplant Recipients (KTR) from 2001-17 using the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry and the Australian and New Zealand Pancreas Islet Transplant Registry (ANZPITR). A total of 19 pregnancies to 15 SPKR mothers, and 348 pregnancies to 235 KTR mothers were reported. Maternal ages were similar (SPKR 33.9 ± 3.9 years; KTR 32.1 ± 4.8 years, p = .10); however, SPKR had a shorter transplant to first-pregnancy interval compared to KTR (SPKR 3.3 years, IQR (1.7, 4.1); KTR 5 years, IQR (2.6, 8.7), p = .02). Median difference in creatinine pre- and post-pregnancy was similar between the groups (KTR -3 µmol/L, IQR (-15, 6), SPKR -3 µmol/L, IQR (-11, 3), p = .86). Maternal, fetal and kidney transplant outcomes were similar despite higher rates of pre-existing peripheral vascular and coronary artery diseases in SPKR. Live birth rates (>20 weeks) were comparable (SPKR 93.8% vs. KTR 96.8%, p = .06). KTR with either type 1 or type 2 diabetes mellitus (24 births) had similar outcomes compared to SPKR. In this national cohort, pregnancy outcomes were similar between SPKR and KTR mothers; however, findings should be interpreted with caution due to small sample sizes.

Identifiants

pubmed: 33179349
doi: 10.1111/ctr.14151
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14151

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Sureshkumar KK, Patel BM, Markatos A, Nghiem DD, Marcus RJ. Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease. Clin Transplant. 2006;20(1):19-25.
La Rocca E, Fiorina P, di Carlo V, et al. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int. 2001;60(5):1964-1971.
Lessan-Pezeshki M, Ghazizadeh S, Khatami MR, et al. Fertility and contraceptive issues after kidney transplantation in women. Transpl Proc. 2004;36(5):1405-1406.
Jesudason S, Tong A. The patient experience of kidney disease and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019;57:77-88.
Bramham K, Lightstone L, Taylor J, et al. Pregnancy in pancreas-kidney transplant recipients: report of three cases and review of the literature. Obstet Med. 2010;3(2):73-77.
Levidiotis V, Chang S, McDonald S. Pregnancy and maternal outcomes among kidney transplant recipients. J Am Soc Nephrol. 2009;20(11):2433-2440.
Wyld ML, Clayton PA, Jesudason S, Chadban SJ, Alexander SI. Pregnancy outcomes for kidney transplant recipients. Am J Transplant. 2013;13(12):3173-3182.
Cruz Lemini MC, Ibarguengoitia Ochoa F, Villanueva Gonzalez MA. Perinatal outcome following renal transplantation. Int J Gynaecol Obstet. 2007;96(2):76-79.
Mohammadi FA, Borg M, Gulyani A, McDonald SP, Jesudason S. Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation. Clin Transplant. 2017;31(10):e13089.
Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation. 2007;83(10):1301-1307.
Cabiddu G, Spotti D, Gernone G, et al. A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology. J Nephrol. 2018;31(5):665-681.
Rodriguez Faba O, Boissier R, Budde K, et al. European Association of Urology Guidelines on Renal Transplantation: Update 2018. Eur Urol Focus. 2018;4(2):208-215.
Shah S, Venkatesan RL, Gupta A, et al. Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol. 2019;20(1):24.
Armenti VT, Daller JA, Constantinescu S, et al. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Clin Transpl. California: Terasaki Research Institute; 2006;57-70.
Fang YE, Nayyar R, Diplock H. An audit of pregnancy outcomes in solid organ transplant recipients at a metropolitan hospital. Aust N Z J Obstet Gynaecol. 2019;59(1):102-104.
Normand G, Brunner F, Badet L, et al. Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study. Transpl Int. 2017;30(9):893-902.
Wilson GA, Coscia LA, McGrory CH, et al. National transplantation pregnancy registry: postpregnancy graft loss among female pancreas-kidney recipients. Transpl Proc. 2001;33(1-2):1667-1669.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
Australian Institute of Health and Welfare. Australia’s mothers and babies 2016-in brief. Perinatal statistics this research group is currently undertaking data linkage to perinatal datasets that may provide these elements in the future42 series no. 34. Cat. no. PER 97. Canberra: AIHW; 2018.
Bramham K. Pregnancy in renal transplant recipients and donors. Semin Nephrol. 2017;37(4):370-377.
Thornton C, Dahlen H, Korda A, Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol. 2013;208(6):476.e1-5.
Brosens I, Brosens JJ, Benagiano G. The risk of obstetrical syndromes after solid organ transplantation. Best Pract Res Clin Obstet Gynaecol. 2014;28(8):1211-1221.
Fitzpatrick A, Mohammadi F, Jesudason S. Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby. Int J Womens Health. 2016;8:273-285.
Thompson BC, Kingdon EJ, Tuck SM, Fernando ON, Sweny P. Pregnancy in renal transplant recipients: the Royal Free Hospital experience. QJM. 2003;96(11):837-844.
Svetitsky S, Baruch R, Schwartz IF, et al. Long-term effects of pregnancy on renal graft function in women after kidney transplantation compared with matched controls. Transpl Proc. 2018;50(5):1461-1465.
Gutierrez MJ, Acebedo-Ribo M, Garcia-Donaire JA, et al. Pregnancy in renal transplant recipients. Transpl Proc. 2005;37(9):3721-3722.
van Buren MC, Schellekens A, Groenhof TKJ, et al. Long term graft survival and graft function following pregnancy in kidney transplant recipients: a systematic review and meta-analysis. Transplantation. 2019;104(8):1675-1685.
Webster AC, Hedley JA, Anderson PF, et al. Australia and New Zealand islet and pancreas transplant registry annual report 2018-islet donations, islet isolations, and islet transplants. Transpl Direct. 2019;5(2):e421.
Rose C, Gill J, Zalunardo N, Johnston O, Mehrotra A, Gill JS. Timing of pregnancy after kidney transplantation and risk of allograft failure. Am J Transplant. 2016;16(8):2360-2367.
Abeywardana S, Sullivan EA. Congenital Anomalies in Australia 2002-2003. Birth Anomalies Series no. 3, Cat. no. PER 41. Sydney: AIHW National Perinatal Statistics Unit; 2008.
Coscia LA, Armenti DP, King RW, Sifontis NM, Constantinescu S, Moritz MJ. Update on the teratogenicity of maternal mycophenolate mofetil. J Pediatr Genet. 2015;4(2):42-55.
Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82(12):1698-1702.
Perez-Aytes A, Ledo A, Boso V, et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A. 2008;146a(1):1-7.
Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. California: Terasaki Research Institute; 2002;121-130.
Deshpande NA, James NT, Kucirka LM, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11(11):2388-2404.
Perales-Puchalt A, Vila Vives JM, Lopez Montes J, Diago Almela VJ, Perales A. Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison. J Matern Fetal Neonatal Med. 2012;25(8):1363-1366.
Carta P, Caroti L, Zanazzi M. Pregnancy in a kidney transplant patient treated with everolimus. Am J Kidney Dis. 2012;60(2):329.
Margoles HR, Gomez-Lobo V, Veis JH, Sherman MJ, Moore J Jr. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report. Transpl Proc. 2014;46(1):281-283.
Veroux M, Corona D, Veroux P. Pregnancy under everolimus-based immunosuppression. Transpl Int. 2011;24(12):e115-e117.
Tong A, Brown MA, Winkelmayer WC, Craig JC, Jesudason S. Perspectives on pregnancy in women With CKD: a semistructured interview study. Am J Kidney Dis. 2015;66(6):951-961.
Mohammadi F, McDonald S, Clark E, Jesudason S. Two pregnancies after simultaneous pancreas-kidney transplantation: a case report. Obstet Med. 2020;13(2):92-95.
Hewawasam E, Gulyani A, Davies CE, et al. Parenthood and pregnancy in Australians receiving treatment for end-stage kidney disease: protocol of a national study of perinatal and parental outcomes through population record linkage. BMJ Open. 2020;10(5):e036329.

Auteurs

Joanne Tang (J)

Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Aarti Gulyani (A)

Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and Australian and New Zealand Organ Donation Registry (ANZOD), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.

Erandi Hewawasam (E)

Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and Australian and New Zealand Organ Donation Registry (ANZOD), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Stephen McDonald (S)

Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and Australian and New Zealand Organ Donation Registry (ANZOD), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Phil Clayton (P)

Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and Australian and New Zealand Organ Donation Registry (ANZOD), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Angela C Webster (AC)

School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Centre for Transplant and Renal Research, Westmead Hospital, Westmead, New South Wales, Australia.

John Kanellis (J)

Department of Nephrology, Monash Health and Centre for Inflammatory Diseases, Clayton, Victoria, Australia.
Department of Medicine, Monash University, Clayton, Victoria, Australia.

Shilpanjali Jesudason (S)

Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and Australian and New Zealand Organ Donation Registry (ANZOD), South Australian Health & Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH